Clinical characteristics of patients with acute ischemic stroke for whom angiography showed reocclusion after initial recanalization
| Patient No. | Age (yr)/Sex | Initial NIHSS Score | Site and Initial Grade* of Occlusion | ACT (s) | Treatment before Reocclusion | Treatment for Reocclusion† | Final Gradeb of Occlusion | Outcomed |
|---|---|---|---|---|---|---|---|---|
| 1 | 76/M | 26 | MCA, 3A | 269 | Reteplase (3 U), snare (n = 1) | Reteplase (1U), snare (n = 1), angioplasty (n = 1) | 2 | Death |
| 2 | 84/M | 18 | MCA, 3A | 252 | Reteplase (3 U) | Reteplase (1 U) | 1 | Death |
| 3 | 87/M | 21 | MCA, 3B | 251 | Reteplase (2 U), snare (n = 1), angioplasty (n = 2) | Reteplase (1 U), angioplasty (n = 1) | 2 | Death |
| 4 | 68/M | 32 | ICA, 5 | 255 | Reteplase (3 U), snare (n = 1) | Angioplasty (n = 1), 2.5 × 12-mm S660 stent (n = 1) | 1 | Death |
| 5 | 50/F | 26 | MCA, 3A | NA | Reteplase (3 U), angioplasty (n = 1) | Reteplase (1 U), angioplasty (n = 1) | 2 | Death |
| 6 | 83/M | 14 | MCA, 3A | 250 | Reteplase (3 U), angioplasty (n = 1) | Reteplase (2 U), snare (n = 1), 2.25 × 13-mm Bx VELOCITY stent (n = 1) | 3A | mRS 4 |
| 7 | 73/M | 30 | BA, 4B | NA | Reteplase (3 U), angioplasty (n = 1) | Reteplase (1 U), snare (n = 1) | 4A | Death |
| 8 | 75/F | 20 | ICA, 4A | 257 | Reteplase (2 U), snare (n = 1) | Reteplase (2 U), snare (n = 1), angioplasty (n = 1) | 2 | mRS 5 |
Note.—NIHSS indicates National Institutes of Health Stroke Scale; ACT, activated coagulation time; M, male; F, female; MCA, middle cerebral artery; ICA, internal carotid artery; BA, basilar artery; NA, not available; mRS, modified Rankin scale.
* Grading system from Qureshi AI (7).
† S660 stents were manufactured by Guidant, Temecula, CA; Bx VELOCITY stents were manufactured by Cordis, Miami Lakes, FL.
‡ mRS scores were determined at follow-up 1 to 3 months after thrombolysis.